Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 19188814)

1.

MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1.

Zheng K, Liu W, Liu Y, Jiang C, Qian Q.

Oncol Lett. 2015 Feb;9(2):869-874. Epub 2014 Dec 1.

2.

Fascin1 expression in high-grade serous ovarian carcinoma is a prognostic marker and knockdown of fascin1 suppresses the proliferation of ovarian cancer cells.

Park SH, Song JY, Kim YK, Heo JH, Kang H, Kim G, An HJ, Kim TH.

Int J Oncol. 2014 Mar;44(3):637-46. doi: 10.3892/ijo.2013.2232. Epub 2013 Dec 30.

3.

Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma.

Gun BD, Bahadir B, Bektas S, Barut F, Yurdakan G, Kandemir NO, Ozdamar SO.

Diagn Pathol. 2012 Jul 11;7:80. doi: 10.1186/1746-1596-7-80.

5.

Fascin promotes the motility and invasiveness of pancreatic cancer cells.

Xu YF, Yu SN, Lu ZH, Liu JP, Chen J.

World J Gastroenterol. 2011 Oct 28;17(40):4470-8. doi: 10.3748/wjg.v17.i40.4470.

6.

The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer.

Kanaan Z, Qadan M, Eichenberger MR, Galandiuk S.

Genet Test Mol Biomarkers. 2010 Jun;14(3):347-53. doi: 10.1089/gtmb.2009.0197.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk